European regulators have recommended expanding Maviret, a dual direct-acting antiviral, to include acute hepatitis C infection in adults and children.

The long-term health consequences of COVID-19 have refocused our attention on post-acute infection syndromes (PAIS), starting a discussion on the need for a complete understanding of multisystemic ...

Professor Diane Griffin from the Johns Hopkins Bloomberg School of Public Health, USA, has recently explained the persistence mechanism of viral RNA in the human body after clinical recovery from ...

New research implies that a first-of-its-kind drug for hepatitis B could allow some patients to stop treatment without ...

Short- and long-course intravenous (IV) antibiotics yield comparable treatment success rates in pediatric patients with uncomplicated bone and joint infections (BJIs), according to study results ...

When treating acute infections in patients, health care providers must be able to quickly and accurately identify the best antibiotics for fighting the infection. A research team led by researchers ...

Please provide your email address to receive an email when new articles are posted on . In last month’s editorial — “Infection-associated chronic conditions: Why aren’t we talking about these ...

Human immunodeficiency virus (HIV) attacks CD4 cells, which are a small part of the white blood cells. In acute HIV, white blood cell count may drop slightly but still look “normal.” A white blood ...

In a recent review published in the journal Nature Medicine, researchers summarized known literature findings of the unexplained post-acute infection syndromes (PAISs). Unfortunately, the chronic ...